Literature DB >> 22407140

Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Georg Widhalm1, Georgi Minchev, Adelheid Woehrer, Matthias Preusser, Barbara Kiesel, Julia Furtner, Aygül Mert, Antonio Di Ieva, Boguslaw Tomanek, Daniela Prayer, Christine Marosi, Johannes A Hainfellner, Engelbert Knosp, Stefan Wolfsberger.   

Abstract

Stereotactic biopsies represent a routine neurosurgical procedure for the diagnosis of intracranial lymphomas and selected diffusely infiltrating gliomas. Acquisition of tissue samples that do not allow correct tumor typing and grading is, however, not uncommon. Five-aminolevulinic acid (5-ALA) has been shown to accumulate in malignant tumor tissue. The aim of this study was to prospectively investigate the clinical usability of 5-ALA for intraoperative detection of representative tissue in stereotactic tumor biopsies. Fifty consecutive patients underwent frameless stereotactic biopsy for a suspected brain tumor. 5-ALA was administered 4 h before anesthesia. Serial biopsy samples were obtained and intraoperatively checked for 5-ALA fluorescence (strong, vague, or none) using a modified neurosurgical microscope. All samples were examined for the presence of representative tumor tissue according to neuroimaging (MRI, positron emission tomography, and/or chemical shift imaging) and histopathological parameters. Visible 5-ALA fluorescence was observed in 43/50 patients (strong in 39 and vague fluorescence in four cases). At biopsy target, 52/53 samples of glioblastomas, 9/10 samples of gliomas grade III, and 14/16 samples of lymphomas revealed strong 5-ALA fluorescence. Samples with strong 5-ALA fluorescence were only observed at, but not outside the biopsy target. All tissue samples with strong 5-ALA fluorescence were representative according to our neuroimaging and histopathological criteria (positive predictive value of 100%). Our data indicate that strong 5-ALA fluorescence is a reliable and immediately available intraoperative marker of representative tumor tissue of malignant gliomas and intracranial lymphomas in stereotactic biopsies. Thereby, the application of 5-ALA in stereotactic brain tumor biopsies may in future reduce costs for operating room and neuropathology and may decrease procedure-related morbidity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407140     DOI: 10.1007/s10143-012-0374-5

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  36 in total

1.  Anatomical landmarks for image registration in frameless stereotactic neuronavigation.

Authors:  Stefan Wolfsberger; K Rössler; R Regatschnig; K Ungersböck
Journal:  Neurosurg Rev       Date:  2002-03       Impact factor: 3.042

2.  Stereotactic brain biopsies and operative complications: technique to further decrease risks.

Authors:  R D Dickerman; M A Mittler; J T Morgan
Journal:  Acta Neurochir (Wien)       Date:  2005-08       Impact factor: 2.216

3.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

4.  Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens.

Authors:  Fügen V Aker; Tayfun Hakan; Selhan Karadereler; Murat Erkan
Journal:  Neuropathology       Date:  2005-09       Impact factor: 1.906

Review 5.  Role of stereotactic biopsy in the diagnosis and management of brain tumors.

Authors:  M D Krieger; P T Chandrasoma; C S Zee; M L Apuzzo
Journal:  Semin Surg Oncol       Date:  1998 Jan-Feb

6.  Establishing a benchmark for complications using frame-based stereotactic surgery.

Authors:  L Dade Lunsford; Ajay Niranjan; Aftab A Khan; Douglas Kondziolka
Journal:  Stereotact Funct Neurosurg       Date:  2008-07-26       Impact factor: 1.875

7.  Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Maurice Lipszyc; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Neurosurg       Date:  2004-09       Impact factor: 5.115

8.  Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue.

Authors:  W Stummer; H Stepp; G Möller; A Ehrhardt; M Leonhard; H J Reulen
Journal:  Acta Neurochir (Wien)       Date:  1998       Impact factor: 2.216

9.  Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.

Authors:  Elvis J Hermann; Elke Hattingen; Joachim K Krauss; Gerhard Marquardt; Ulrich Pilatus; Kea Franz; Matthias Setzer; Thomas Gasser; Dominique S Tews; Friedhelm E Zanella; Volker Seifert; Heinrich Lanfermann
Journal:  Stereotact Funct Neurosurg       Date:  2008-09-15       Impact factor: 1.875

10.  [11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.

Authors:  Christian Pötzi; Alexander Becherer; Christine Marosi; Georgios Karanikas; Monika Szabo; Robert Dudczak; Kurt Kletter; Susanne Asenbaum
Journal:  J Neurooncol       Date:  2007-05-11       Impact factor: 4.506

View more
  17 in total

1.  Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas.

Authors:  Mario Mischkulnig; Thomas Roetzer-Pejrimovsky; Daniela Lötsch-Gojo; Nina Kastner; Katharina Bruckner; Romana Prihoda; Alexandra Lang; Mauricio Martinez-Moreno; Julia Furtner; Anna Berghoff; Adelheid Woehrer; Walter Berger; Georg Widhalm; Barbara Kiesel
Journal:  Front Med (Lausanne)       Date:  2022-05-18

2.  Correlation of Tumor Pathology with Fluorescein Uptake and MRI Contrast-Enhancement in Stereotactic Biopsies.

Authors:  Ran Xu; Judith Rösler; Wanda Teich; Josefine Radke; Anton Früh; Lea Scherschinski; Julia Onken; Peter Vajkoczy; Martin Misch; Katharina Faust
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

3.  Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.

Authors:  Johannes Knipps; Igor Fischer; Lisa M Neumann; Marion Rapp; Maxine Dibué-Adjei; Christiane Freiin von Saß; Jan-Malte Placke; Hendrik-Jan Mijderwijk; Hans-Jakob Steiger; Michael Sabel; Jan-Frederick Cornelius; Marcel A Kamp
Journal:  Clin Exp Metastasis       Date:  2019-08-02       Impact factor: 5.150

4.  5-ALA fluorescence and laser Doppler flowmetry for guidance in a stereotactic brain tumor biopsy.

Authors:  Neda Haj-Hosseini; Johan C O Richter; Peter Milos; Martin Hallbeck; Karin Wårdell
Journal:  Biomed Opt Express       Date:  2018-04-20       Impact factor: 3.732

Review 5.  Fluorescence-guided surgery for brain tumors.

Authors:  Martin Hefti
Journal:  CNS Oncol       Date:  2013-01

Review 6.  What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

Authors:  Costas G Hadjipanayis; Georg Widhalm; Walter Stummer
Journal:  Neurosurgery       Date:  2015-11       Impact factor: 4.654

7.  Fluorescein-assisted stereotactic needle biopsy of brain tumors: a single-center experience and systematic review.

Authors:  Giuseppe Catapano; Francesco Giovanni Sgulò; Vincenzo Seneca; Giuseppina Iorio; Matteo de Notaris; Giuseppe di Nuzzo
Journal:  Neurosurg Rev       Date:  2018-01-30       Impact factor: 3.042

Review 8.  Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.

Authors:  Marcel A Kamp; Zarela Krause Molle; Christopher Munoz-Bendix; Marion Rapp; Michael Sabel; Hans-Jakob Steiger; Jan F Cornelius
Journal:  Neurosurg Rev       Date:  2016-05-25       Impact factor: 3.042

9.  Correlation between contrast enhancement on intraoperative magnetic resonance imaging and histopathology in glioblastoma.

Authors:  Pieter L Kubben; Pieter Wesseling; Martin Lammens; Olaf E M G Schijns; Mariël P Ter Laak-Poort; Jacobus J van Overbeeke; Henk van Santbrink
Journal:  Surg Neurol Int       Date:  2012-12-26

10.  5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.

Authors:  Georg Widhalm; Barbara Kiesel; Adelheid Woehrer; Tatjana Traub-Weidinger; Matthias Preusser; Christine Marosi; Daniela Prayer; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.